Active	Status	Sponsor type	Region	Phase	Filter
4 Active 6 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pagan, Fernando L
NCT05885360: Istradefylline Effect Protocol on Parkinson's Disease Tremor	Completed	4	27	US	Istradefylline Pill, NOURIANZ	Georgetown University, Kyowa Kirin, Inc.	Parkinson Disease, Tremor	02/24	02/25
NCT03996460: K0706 for Patients Diagnosed With Dementia With Lewy Bodies	Recruiting	2	45	US	Placebo, 192 mg powder of K0706, 384 mg powder of K0706	Georgetown University, Sun Pharma Advanced Research Company Limited	Dementia With Lewy Bodies	06/23	10/23
NCT04002674: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies	Recruiting	2	60	US	Placebo oral capsule, Placebo, Nilotinib Oral Capsule, Tasigna	Georgetown University, National Institutes of Health (NIH)	Dementia With Lewy Bodies	12/23	12/23
NCT03655236: PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706	Terminated	2	513	Europe, US, RoW	K0706, placebo	Sun Pharma Advanced Research Company Limited	Early Parkinson Disease	04/24	06/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pagan, Fernando L
NCT05885360: Istradefylline Effect Protocol on Parkinson's Disease Tremor	Completed	4	27	US	Istradefylline Pill, NOURIANZ	Georgetown University, Kyowa Kirin, Inc.	Parkinson Disease, Tremor	02/24	02/25
NCT03996460: K0706 for Patients Diagnosed With Dementia With Lewy Bodies	Recruiting	2	45	US	Placebo, 192 mg powder of K0706, 384 mg powder of K0706	Georgetown University, Sun Pharma Advanced Research Company Limited	Dementia With Lewy Bodies	06/23	10/23
NCT04002674: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies	Recruiting	2	60	US	Placebo oral capsule, Placebo, Nilotinib Oral Capsule, Tasigna	Georgetown University, National Institutes of Health (NIH)	Dementia With Lewy Bodies	12/23	12/23
NCT03655236: PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706	Terminated	2	513	Europe, US, RoW	K0706, placebo	Sun Pharma Advanced Research Company Limited	Early Parkinson Disease	04/24	06/24